GPs want more education from endocrinologists on the use of T2D therapies such as SGLT2 inhibitors, but finding the time and getting the format right appears to be a challenge for all parties. A study into why GPs are reluctant to take advantage of the extra-glycaemic benefits of SGLT2 inhibitors in type 2 diabetes has ...
Type 2 diabetes
Endocrinologist education sought by GPs on complex T2D therapy choices
By Michael Woodhead
14 Sep 2021